Cystatin M/E (Cystatin 6): A Janus-Faced Cysteine Protease Inhibitor with Both Tumor-Suppressing and Tumor-Promoting Functions
Alongside its contribution in maintaining skin homeostasis and its probable involvement in fetal and placental development, cystatin M/E (also known as cystatin 6) was first described as a tumor suppressor of breast cancer. This review aims to provide an update on cystatin M/E with particular attent...
Main Authors: | Gilles Lalmanach, Mariana Kasabova-Arjomand, Fabien Lecaille, Ahlame Saidi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/8/1877 |
Similar Items
-
The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
by: Alexis David, et al.
Published: (2023-03-01) -
Protease activity of legumain is inhibited by an increase of cystatin E/M in the DJ-1-knockout mouse spleen, cerebrum and heart
by: Takuya Yamane, et al.
Published: (2017-03-01) -
Secreted cystatins decrease proliferation and enhance apoptosis of human leukemic cells
by: Samar Hunaiti, et al.
Published: (2020-10-01) -
The cystatin superfamily of proteinase inhibitors /
by: 357692 Taupin, Philippe
Published: (c200) -
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer Progression
by: Zijun Zhang, et al.
Published: (2023-11-01)